The present invention provides the synthetic method and superparamagnetic
iron oxide nanoparticles capable of targeting to the folic acid receptors
existing on the cell membranes and with high relaxivity. The iron oxide
nanoparticles of the present invention can further be used as the
contrast agents for magnetic resonance imaging (MRI).